Fresenius Medical Care AG & Co. KGaA (FMS) Stock Overview
Explore Fresenius Medical Care AG & Co. KGaA’s financial performance, market position, analyst ratings, and future outlook.
Fresenius Medical Care AG & Co. KGaA (FMS)
Key Financials
Key Financials
Market Cap
13.4B
P/E Ratio
13.24
EPS (TTM)
$2.52
ROE
0.07%
FMS Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Fresenius Medical Care AG & Co. KGaA (NYSE: FMS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Fresenius Medical Care AG & Co. KGaA's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of FMS on the NYSE shows an RSI of 64.72, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $21.92 for the NYSE listing.
Key metrics behind Fresenius Medical Care AG & Co. KGaA's NYSE-traded stock include a P/E ratio of 13.24 and a market capitalization of 13.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of FMS on the NYSE.